Anavex Life Sciences Corp (AVXL)

[TomP1]

There has been zero communication about the MTA since the PR announcing it has been released and the occasional name dropping by Missling in presentations.

Might I also add that BIIB didn't even bother to communicate about this MTA. For any big pharma an MTA is a cheap shot at trying something out for peanuts. The reward is for biotech to reap if big pharma likes it.

So far we know nothing about the results of what happened at BIIB.

Again, I do hope the results are good, but at this stage I see no factual evidence in the public sphere. So far all we have is deductive logical arguments to conclude why retail investors thinks that BIIB liked A2-73 in MS.